Youcare Pharmaceutical Group Co. Ltd. A (688658) - Total Assets
Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) holds total assets worth CN¥5.19 Billion CNY (≈ $759.04 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Youcare Pharmaceutical Group Co. Ltd. A total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Youcare Pharmaceutical Group Co. Ltd. A - Total Assets Trend (2017–2025)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Check Youcare Pharmaceutical Group Co. Ltd. A (688658) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Youcare Pharmaceutical Group Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Youcare Pharmaceutical Group Co. Ltd. A's total assets of CN¥5.19 Billion consist of 49.7% current assets and 50.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.6% |
| Accounts Receivable | CN¥646.01 Million | 12.4% |
| Inventory | CN¥465.11 Million | 8.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥443.26 Million | 8.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Youcare Pharmaceutical Group Co. Ltd. A (688658) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Youcare Pharmaceutical Group Co. Ltd. A's current assets represent 49.7% of total assets in 2025, a decrease from 56.3% in 2017.
- Cash Position: Cash and equivalents constituted 19.6% of total assets in 2025, down from 22.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 5.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 12.4% of total assets.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Total Assets
Key competitors of Youcare Pharmaceutical Group Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $8.68 Billion |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.98 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
China | CN¥6.82 Billion |
|
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
|
China | CN¥3.25 Billion |
Youcare Pharmaceutical Group Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.97 | 2.17 | 2.53 |
| Quick Ratio | 1.60 | 1.71 | 2.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.24 Billion | CN¥1.64 Billion | CN¥2.10 Billion |
Youcare Pharmaceutical Group Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Youcare Pharmaceutical Group Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.95 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -9.3% |
| Total Assets | CN¥5.21 Billion |
| Market Capitalization | $867.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Youcare Pharmaceutical Group Co. Ltd. A's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Youcare Pharmaceutical Group Co. Ltd. A's assets decreased by 9.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
The table below shows the annual total assets of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.21 Billion ≈ $761.98 Million |
-9.25% |
| 2024-12-31 | CN¥5.74 Billion ≈ $839.67 Million |
-2.93% |
| 2023-12-31 | CN¥5.91 Billion ≈ $865.01 Million |
-1.62% |
| 2022-12-31 | CN¥6.01 Billion ≈ $879.23 Million |
+4.92% |
| 2021-12-31 | CN¥5.73 Billion ≈ $838.01 Million |
+4.94% |
| 2020-12-31 | CN¥5.46 Billion ≈ $798.53 Million |
+57.39% |
| 2019-12-31 | CN¥3.47 Billion ≈ $507.36 Million |
+1.43% |
| 2018-12-31 | CN¥3.42 Billion ≈ $500.21 Million |
-2.46% |
| 2017-12-31 | CN¥3.50 Billion ≈ $512.80 Million |
-- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central… Read more